Blonanserin
Blonanserin (AD-5423) is an atypical antipsychotic approved in Japan in 2008. It exhibits a favorable tolerability profile with reduced risks of extrapyramidal symptoms, sedation, and hypotension. Research applications include in vitro receptor binding studies and in vivo models for psychosis and schizophrenia.
Product Specifications
CAS Number
132810-10-7
Product Name Alternative
D2, Dopamine Receptor, DopamineReceptor, Dopamine, Beta Receptor, 5HTReceptor, 5-hydroxytryptamine Receptor, 5HT Receptor, 5-HT Receptor, 5-HT2, AdrenergicReceptor, AD-5423, AD5423, AD 5423, Adrenergic Receptor, Blonanserin, antipsychotic, inhibit, excessive sedation, extrapyramidal symptom, Inhibitor, hypotension, social deficit, schizophrenia, Serotonin Receptor, Sigmareceptor, Sigma Receptor, Sigma receptor
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
99.85% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.72 mM) ; DMSO:14.29 mg/mL (38.88 mM)
Smiles
FC1=CC=C (C2=C3C (=NC (=C2) N4CCN (CC) CC4) CCCCCC3) C=C1
Molecular Formula
C23H30FN3
Molecular Weight
367.50
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
